Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Anebulo Pharmaceuticals, Inc. (ANEB)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Jun-30-20 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 8-K |
| Assets |
| Cash and equivalents | 14.2 | 14.5 | 16.5 | 18.0 | 19.2 | 20.0 | 3.3 | 3.0 |
| Accounts receivable, net | | | | | | | | 0.0 |
| Other current assets | 0.3 | 1.0 | 0.8 | 1.4 | 2.1 | 1.7 | 0.6 | |
| Total current assets | 14.4 | 15.6 | 17.4 | 19.4 | 21.3 | 21.7 | 3.9 | 3.0 |
| Total assets | 14.4 | 15.6 | 17.2 | 19.0 | 20.5 | 21.7 | 4.3 | 3.0 |
| |
| Accounts payable | 0.6 | 0.4 | 0.1 | 0.0 | 0.5 | 0.1 | 0.1 | |
| Accrued expenses | 0.9 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Short-term debt | | | | | | | | 0.2 |
| Total current liabilities | 1.5 | 0.5 | 0.1 | 0.0 | 0.6 | 0.2 | 0.3 | 0.2 |
| Other liabilities | | | | | | | 10.5 | |
| Total liabilities | 1.5 | 0.5 | 0.1 | 0.0 | 0.6 | 0.2 | 10.8 | 0.2 |
| |
| Shareholders' equity [+] | 12.9 | 15.1 | 17.2 | 18.9 | 19.9 | 21.4 | -6.5 | 2.8 |
| Paid-in capital | 67.6 | 60.5 | 60.3 | 60.2 | 60.1 | 60.0 | 0.1 | |
| Retained earnings | -54.7 | -45.5 | -43.1 | -41.3 | -40.2 | -38.6 | -9.5 | -0.2 |
| Tangible shareholders' equity | 12.9 | 15.1 | 17.2 | 18.9 | 19.9 | 21.4 | -6.5 | 2.8 |
|